Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ORGS Stock Forecast, Price Targets, Chart, Dividends & Analysis

Orgenesis Inc. logo

Orgenesis Inc.

Sector: Healthcare   

Industry: Biotechnology

3.82
 
USD
  
-0.12
  
(-3.04%)
Previous close: 3.94  Open: 3.8001  Bid: 3.82  Ask: 3.99
52 week range    
0.25   
   5.44
Mkt Cap: 19 M  Avg Vol (90 Days): 173,779
Peers   
NWBO / 
NYMX / 
OHCS / 
Last updated: Friday 11th October 2024

Stock Rankings

60
MarketXLS Rank
60
Value
69
Technical
52
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

NWBO

NYMX

0.2

OHCS

OMIC

0 B014.31
Financials

ORGS Income Statement

Annual
Nov-14Nov-15Nov-16Nov-17Nov-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles1 M2 M2 M2 M430000.0478000.0948000.0911000.0721000.0
Basic EPS from continuing operations4.171.480.591.91
Basic EPS total1.20.961.081.281.431.77-0.581.480.59-1.91
Basic weighted shares outstanding5 M5 M9 M10 M13 M16 M21,320 M24 M25 M29 M
BasicDiscontinuousOperations-4.75
Cost of sales-4 M-8 M-7 M-11 M-18 M31 M29 M21 M6 M
Depreciation-3 M-3 M-3 M-634000.0705000.0916000.01 M2 M
Depreciation unreconciled1 M2 M2 M2 M430000.0478000.0948000.0911000.0721000.0
DepreciationAndAmortization1 M2 M2 M2 M430000.0478000.0948000.0911000.0721000.0
Diluted EPS total1.321.321.081.311.431.77-0.581.480.59-1.91
Diluted normalized net income/share1.91
Diluted weighted shares outstanding5 M5 M9 M10 M13 M16 M21,320 M24 M25 M29 M
Earnings from equity interest-1 M-731000.0106000.0-272000.0-2 M-734000.0
EarningsFromEquityInterestNetOfTax-1 M-731000.0106000.0-272000.0-2 M-734000.0
Fees-27 M
GainOnSaleOfBusiness-5 M
GainOnSaleOfSecurity-123000.026 M2 M2 M
GainsLossOnDisposalOfDiscontinuedOperations3 M966000.0
GeneralAndAdministrativeExpense3 M4 M6 M9 M16 M25 M19 M15 M16 M35 M
Gross operating profit-906000.0-1 M3 M11 M4 M-23 M7 M15 M-6 M
ImpairmentOfCapitalAssets1 M
Income before tax-6 M-5 M-13 M-14 M-18 M23 M-97 M-18 M-12 M-64 M
Income restructuring and M&A-15 M-21 M
Income taxes-900000.0-2 M-1 M1 M229000.0-2 M108000.0209000.0473000.0
Interest income-99000.0
InterestExpenseNonOperating-20000.01 M943000.02 M5000.0
InterestIncomeOperating494000.03 M
MarketingExpense37 M
MinorityInterests813000.0-2 M531000.06000.0-3 M10 M
MiscOtherSpecialCharges-927000.02 M-1 M-2 M-3 M843000.0-1 M-3 M-2 M-3 M
Net income from total operations-11 M-4 M-11 M-12 M-18 M31 M1 M-18 M-15 M-55 M
NetIncomeCommonStockholders-11 M-4 M-11 M-12 M-18 M31 M6 M-18 M-15 M-55 M
NetIncomeContinuousOperations-11 M-4 M-11 M-12 M-18 M31 M1 M-18 M-15 M-62 M
NetIncomeDiscontinuousOperations3 M96 M
NetNonOperatingInterestIncomeExpense-950000.0-3 M-99000.0-3000.0-1000.0-7000.0-5000.0
Normalized income-14 M-8 M
Operating income-10 M-7 M-11 M-10 M-14 M-22 M-96 M-17 M-9 M-54 M
Operating income before depreciation (EBITDA)-5 M-3 M-10 M-11 M-15 M-22 M-94 M-15 M-8 M-59 M
OperatingExpense5 M6 M10 M13 M25 M26 M103 M50 M16 M46 M
Other income net927000.0-2 M1 M4 M4 M-27 M1 M3 M4 M9 M
Other special charges-4000.0-2 M
OtherGainLossFromDispositionOfDiscontinuedOperations96 M
OtherGandA3 M4 M6 M9 M16 M25 M19 M15 M16 M35 M
OtherOperatingExpenses-897000.0-1 M-2 M547000.0-2 M-173000.0-4000.0
ProvisionForGainLossOnDisposal-97 M
RealizedCapitalGain-4 M
RentAndLandingFees3 M4 M6 M9 M16 M25 M-260000.0
Research & development expense2 M1 M2 M2 M6 M14 M84 M37 M11 M
ResearchExpense2 M1 M2 M2 M6 M14 M84 M37 M11 M
RestructringAndMnAIncome-15 M-21 M
Revenue per share1 M2 M2 M2 M430000.0478000.0948000.0911000.0721000.0
SalariesAndWages123000.0-3 M-4 M-3 M3 M2 M982000.0463000.0
Selling Gen & administrative expense3 M4 M6 M9 M16 M11 M19 M51 M16 M35 M
SellingAndMarketingExpense11 M37 M
SellingExpense11 M
Special income/charges15 M21 M4000.02 M-1 M
Total Income available for interest expense (EBIT)-6 M-5 M-13 M-14 M-18 M-25 M-95 M-17 M-10 M-61 M
Total common shares outstanding5 M9 M10 M10 M16 M18 M24 M25 M27 M34 M
Total net income-11 M-4 M-11 M-12 M-18 M31 M1 M-18 M-15 M-55 M
Total ordinary shares47 M47 M47 M47 M47 M47 M47 M47 M47 M47 M
Total revenues-6 M3 M6 M10 M22 M4 M8 M36 M36 M530000.0
TotalExpenses5 M2 M2 M6 M14 M22 M103 M87 M43 M53 M
TotalRevenue3 M6 M10 M19 M3 M8 M36 M36 M530000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University